Aspirin to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication in Adults Ages 50 to 59 Years
Description of Resource:
The U.S. Preventive Services Task Force (USPSTF) recommends low-dose aspirin use for the primary prevention of colorectal cancer in adults ages 50–59 years who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years. This is a B recommendation, which means the USPSTF recommends the service. There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.